Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome

201741 citationsJournal Articlegreen Open Access

Authors

Rocío Múñoz‐Hernández · Hospital Universitario Virgen del Rocío

Pablo Medrano‐Campillo · Hospital Universitario Virgen del Rocío

María Luisa Miranda · Hospital Universitario Virgen del Rocío

Hada C. Macher · Hospital Universitario Virgen del Rocío

Juan Manuel Praena‐Fernández · Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla

Antonio J. Vallejo‐Vaz · Universidad de Sevilla

Abstract

The measured biomarkers of cell damage, angiogenesis, and antiangiogenesis may reflect the severity of PE, with higher levels in patients who develop HELLP syndrome. In addition, these biomarkers may also help predict adverse fetal and maternal outcomes.

Topics & Keywords

Pregnancy and preeclampsia studies Birth, Development, and Health Prenatal Screening and Diagnostics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: American Journal of Hypertension

Volume 30, Issue 7, pp. 673-682

DOI: 10.1093/ajh/hpx024

Field-Weighted Citation Impact: 5.26